Mapi Pharma (Israel)

Mapi Pharma is a late clinical stage pharmaceutical company headquartered in Israel, with R&D facilities in Israel and China, an API production facility in the Neot-Hovav Eco Industrial Park, and a sterile manufacturing and Fill & Finish facility in Jerusalem. The company focuses on developing long-acting depot injectable drugs and life cycle management (LCM) products, with lead programs including GA Depot for multiple sclerosis and long-acting Pregabalin for pain.

Mapi Pharma was founded in January 2008 by Ehud Marom, who has served as CEO and chairman since inception. The company is headquartered in Israel, with R&D facilities in Israel and China, an API production facility in the Neot-Hovav Eco Industrial Park, and a sterile manufacturing and Fill & Finish facility in Jerusalem. It is a late clinical stage pharmaceutical company focused on developing long-acting depot injectable drugs and life cycle management products.

1. 1Mapi Pharma | Formulations That Meet Unmet Patient Needsmapi-pharma.com
2. 2Our Company | Mapi Pharmamapi-pharma.com
3. 3Team | Mapi Pharmamapi-pharma.com
4. 4Our Strategy | Mapi Pharmamapi-pharma.com
5. 5Mapi Pharma (Israel)wikidata.org